Natural Capsules Ltd

EGM Record Date

• Purpose: Record Date for Extraordinary General Meeting (EGM) entitlement.
• EGM date: September 9, 2026.
• Record date: September 2, 2026.

Resolutions

• Resolution 1: Special; preferential equity issue of 1,25,000 shares at ₹160 to promoter Sunil Mundra.
• Total issue size ₹2 crore; fully paid; shares ranking pari passu; lock-in as per ICDR.
• Relevant date for pricing: 10 Aug 2026.
• Proposed allottees: Sunil Mundra (Promoter).
• Resolution 2: Special; issuance of 5,00,000 warrants convertible into equity shares for promoter Sunil Mundra.
• Warrants priced at ₹160; total ₹8 crore; 18-month exercise window; 25% upfront; 75% on exercise.
• Warrants convertible into equity shares; voting rights only on conversion; demat and lock-in.
• Post-issue shareholding pattern indicates promoter holding rising to 53.70% (from 50.92%).
• No change in control; board empowered to modify terms and handle registrations, listings, and approvals.

Shareholding impact

• Promoter shareholding rises from 50.92% to 53.70% after issue.
• Promoter share count rises to 59,26,248 shares.
• Post-issue pattern: Promoters 53.70%, Public 46.30%.

Use of proceeds

• Equity proceeds ₹2 crore to fund working capital and capital expansion.
• Warrant proceeds ₹8 crore to fund working capital and expansion.

Governance impact

• Promoter Sunil Mundra to subscribe to all allotted securities.
• Board authorized to modify terms and handle registrations, listings, and approvals.
• No change in control anticipated from these transactions.

Resignation details

• The material subsidiary is Natural Biogenex Private Limited.
• Mr. Pramod Kasat has resigned as Independent Director.
• The resignation is effective August 17, 2026 due to professional commitments.

Board decisions

• Approved unaudited standalone and consolidated results for quarter ended June 30, 2026.
• Notice of Extra Ordinary General Meeting to be held on September 9, 2026.

Capital actions

• Preferential issue: up to 1,25,000 equity shares to promoter group at Rs 160 each.
• Preferential issue: up to 5,00,000 warrants to promoter group at Rs 160 each.

EGM & governance

• Draft EGM notice approved; details to be filed with stock exchanges.
• Scrutinizer appointed: M/S Deepak Sadhu, Practicing Company Secretaries.

Operational notes

• Standalone Q1 FY2027 results prepared per Ind AS; limited review unmodified.

AGM details

• AGM held on 12 August 2026, 12:10 PM, via video conferencing.
• Venue: Trident Towers, Bengaluru.
• Record date: 5 August 2026.

Key resolutions

• Resolution 1 (Ordinary): Adopt consolidated and standalone financial statements with reports; passed.
• Resolution 2 (Ordinary): Re-appoint Jyoti Mundra as director; passed.
• Resolution 3 (Ordinary): Re-appoint Laxminarayan Moondra as director; passed.
• Resolution 4 (Special): Re-appoint Moondra as Whole-time Director for 3 years; remuneration revised.
• Resolution 5 (Ordinary): Approve related party transactions with Natural Biogenex Private Limited; passed.
• Resolution 6 (Ordinary): Revise remuneration of Shrey Mundra, G.M. Marketing; passed.

Dividend

• No dividend proposed or declared.

Director changes

• Jyoti Mundra re-appointed as director (rotational).
• Laxminarayan Moondra re-appointed as director (rotational).
• Laxminarayan Moondra appointed Whole-time Director for 3 years; remuneration revised.

Auditors

• No auditor appointment or changes disclosed.

Material related party transactions

• Approval of related party transactions with Natural Biogenex Private Limited.

Other material approvals

• No other material approvals announced.